Mubadala

Mubadala Investment Company, established in 2002 by the Government of Abu Dhabi, serves as a principal agent in the diversification of Abu Dhabi's economy. With a focus on generating sustainable financial returns, Mubadala manages a global portfolio of approximately $229 billion, encompassing a wide range of sectors, including aerospace, information and communication technology, semiconductors, renewable energy, healthcare, and real estate. The company is based in Abu Dhabi, with additional offices in key global cities such as Rio de Janeiro, Moscow, New York, and San Francisco. Mubadala is dedicated to addressing pressing regional needs, particularly in healthcare, while also emphasizing strong governance and responsible investment practices. As a trusted partner and engaged shareholder, Mubadala plays a significant role in fostering economic growth and innovation both locally and internationally.

Khalid Al-Rumaihi

Executive Director

Abdulla AlBanna

Partner

Saed Arar

Executive Director

Rami Hannoush

General Partner

Max Holnaicher

Principal

Nabil El Jisr

Senior Vice President - Office of the Chief Corporate and Human Capital Officer

Ana Mostarac

Partner and Head of Operations

Khaldoon Khalifa Al Mubarak

CEO

253 past transactions

3650 Capital

Funding Round in 2025
3650 Capital is a CRE lending and loan servicing firm.

Imepac

Acquisition in 2025
Imepac offers medical courses and programs that builds knowledge and transform lives.

Deel

Secondary Market in 2025
Deel, Inc., also known as Lets Deel, Inc., is a payroll and compliance platform that assists businesses in managing global remote contractors and employees. Founded in 2017 and based in San Francisco, the company offers tools that integrate hiring, human resources, payroll services, contracts, payments, and tax compliance into a single interface. This streamlined approach enhances the experience for both employers and foreign contractors by simplifying the processes of onboarding and payment. Deel provides essential resources such as contracts, templates for tax forms, automated invoicing, and customer support, as well as insurance products related to employment. The platform aims to facilitate the management of a global workforce, making it easier for companies to comply with local regulations while efficiently handling payroll and related services.

Auron Therapeutics

Series B in 2025
Auron Therapeutics is to develop therapies to cure cancer by radically changing the paradigm of cancer therapeutics from cell killing, to transformation of malignant cells into normal cells. This transformation, called differentiation therapy, reactivates endogenous cellular programs to elicit tumor cell maturation and the transition from cancer to normal tissue. Its unique platforms allow for integration of large-omic datasets and miniaturized high throughput flow cytometry to rapidly identify and validate multiple targets and drugs in primary human patient samples.

Global Medical Supply Chain

Acquisition in 2024
Global Medical Supply Chain is a healthcare logistics and medical consumables supply company.

Al Ittihad Drug Store

Acquisition in 2024
Al Ittihad Drug Store operates as a distributor specializing in pharmaceutical and consumer healthcare products. The company caters to pharmacies and supermarkets, providing a diverse selection of therapeutic classes that include antibacterial, hypertension, diabetes, cardiovascular, and anticoagulant medications, in addition to medical devices and consumer health products. Al Ittihad Drug Store is committed to addressing the comprehensive healthcare needs of consumers by ensuring timely deliveries, extensive network coverage, competitive pricing, and tailored services.

9fin

Series B in 2024
9fin Limited, founded in 2016 and based in London, specializes in artificial intelligence software that delivers comprehensive financial data and analytics for the bond market, particularly focusing on high-yield bonds. The company's platform utilizes computer vision and machine learning to aggregate and analyze crucial financial information, enabling users to assess risks and make informed investment decisions. By providing tools that facilitate the search, filtering, and analysis of data, 9fin supports professionals across various sectors, including finance, investment banking, and asset management. The platform also offers real-time monitoring of market events and deal tracking, helping users optimize collaboration and efficiency within their teams.

Odoo

Secondary Market in 2024
Odoo is an open-source platform that offers a comprehensive suite of integrated business applications aimed at managing various company operations. Its tools encompass customer relationship management (CRM), eCommerce, accounting, inventory management, point of sale, and project management, among others. These applications are designed to work cohesively, facilitating seamless workflows across different departments within a business. Odoo enables organizations to automate processes and monitor activities from any device, thus enhancing efficiency and productivity in managing their operations.

Crusoe Energy Systems

Series D in 2024
Crusoe Energy Systems Inc. is a technology company based in Denver, Colorado, focused on addressing operational, environmental, and regulatory challenges in the oil and gas sector. Founded in 2018, the company specializes in its Digital Flare Mitigation solution, which enables upstream operators without pipeline access to convert wasted natural gas into electricity for energy-intensive computing applications. This service provides a cost-effective and straightforward method for oil and gas producers to reduce routine flaring of natural gas, helping them maintain regulatory compliance and support sustainable practices. As the industry faces increasing constraints and regulations regarding natural gas flaring, Crusoe Energy Systems aims to create solutions that benefit both energy producers and local communities.

Flink

Venture Round in 2024
Flink is a Berlin-based company founded in 2020 that specializes in providing an online platform for grocery delivery services. The company enables customers to order a diverse range of grocery products, including fresh herbs, fruits, bread, and essential home supplies, all delivered to their doors within ten minutes. Flink's service is designed to offer convenience at competitive supermarket prices, allowing users to save on transit costs while accessing a wide selection of everyday items quickly and efficiently.

UCB Pharma

Acquisition in 2024
UCB Pharma is a subsidiary of Union Chimique Belge that specializes in neurology and allergies.

Yondr Group

Private Equity Round in 2024
Yondr Group is a developer, owner-operator, and service provider of hyper-scale data centers, addressing the increasing capacity and technical real estate requirements of technology companies. The firm designs, delivers, and operates data center facilities on a global scale, providing clients with tailored, cost-effective solutions that include custom-built rack-ready spaces. Through its comprehensive approach, Yondr Group aims to meet the complex data center capacity demands of businesses in the tech sector.

Firstvet

Series C in 2024
FirstVet is a digital veterinary clinic that offers a video consultation platform to connect pet owners with veterinarians via smartphone, tablet, or computer. Founded in 2016 and headquartered in Stockholm, Sweden, the platform allows users to receive advice on their pets' health and well-being, helping them assess when to seek further care. FirstVet's services include video consultations and medicinal prescriptions, providing a cost-effective and time-efficient alternative to traditional veterinary visits. By leveraging technology, FirstVet aims to enhance pet care and simplify access to veterinary services for pet owners.

Stake

Series A in 2024
Stake is a digital real estate investment platform providing the easiest and most transparent way to invest in income-generating properties, starting in Dubai. Its mission is to make investing in real estate accessible and profitable for all.

Storyblok

Series C in 2024
Storyblok GmbH operates a cloud-based content management platform that enables users to upload, manage, and publish content through its APIs. Founded in 2015 and headquartered in Linz, Austria, Storyblok distinguishes itself with customizable content blocks and visual editing tools, catering to both developers and content editors. Unlike traditional headless content management systems, which may prioritize flexibility for developers, Storyblok emphasizes usability for editors, allowing them to create and manage content without requiring coding skills. The platform includes features such as a visual composer, various content types, and extensive API endpoints for e-commerce, facilitating a seamless user experience while handling complex tasks like order management and multilingual product catalogs.

Arbol

Series B in 2024
Arbol is developing a climate risk assessment and insurance platform aimed at helping businesses analyze and mitigate financial losses from extreme weather events. It operates an insurance marketplace that connects weather-exposed agricultural entities with capital providers, such as insurers and asset managers. By leveraging objective data from satellites, weather stations, and advanced technologies like big data, artificial intelligence, and blockchain, Arbol's parametric insurance platform enhances transparency and efficiency in managing climate risks. The platform offers automated pricing and instant payouts triggered by objective data, reducing administrative costs and information asymmetry, thereby enabling businesses across various industries to effectively address their climate-related financial challenges.

Metsera

Series A in 2024
Metsera is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for obesity and metabolic conditions. The company focuses on advancing a variety of oral and injectable treatment options, including incretin, non-incretin, and combination therapies. These treatments are designed to address multiple therapeutic targets, positioning Metsera to meet the evolving demands of the weight loss treatment landscape. Additionally, Metsera integrates proprietary health technology tools to provide personalized care, enhancing the effectiveness of its therapeutic offerings.

Flip

Series C in 2024
Flip is a social shopping app that merges social media and e-commerce, allowing customers to engage with beauty products through video reviews. The platform enables users to discover products via short, user-generated videos, creating a dynamic shopping experience. Customers can receive clothing tailored to their preferences and share their try-on photos within the Flip community, seeking feedback from friends to enhance their decision-making process. By facilitating instant access to a community of shoppers and creators, Flip provides brands with tools to launch social commerce initiatives and connect with potential buyers. The platform emphasizes peer validation, enabling shoppers to make informed purchases with a seamless one-click checkout option.

Avanse Financial Services

Private Equity Round in 2024
Avanse Financial Services Limited is a non-banking financial company based in Mumbai, India, specializing in education financing for students. Established in 1992, the company provides a range of financial solutions including loans for higher education in India and abroad, e-learning initiatives, and vocational training programs. Avanse also offers loans to educational institutions to support their operational and growth needs. The company's goal is to ensure that deserving students have access to affordable financing options to cover course fees and living expenses, without a cap on the loan amount. By leveraging technology, Avanse aims to streamline the loan application process and enhance access to education-related financial support across the entire educational ecosystem, from pre-school to post-graduation.

KELIX Bio

Acquisition in 2024
KELIX bio is a specialty generic business focused on delivering high complexity products to underserved populations across emerging markets.

Capstan Therapeutics

Series B in 2024
Capstan Therapeutics is a biotechnology company focused on enhancing the therapeutic potential of in vivo RNA-based therapies. It develops proprietary targeted delivery systems, including targeted lipid nanoparticles, to improve the efficacy and control of dosage in engineered cell therapies. This innovative platform aims to address a variety of diseases, particularly in the fields of oncology, fibrosis, and inflammation, where there are significant unmet clinical needs. By advancing precision in vivo cell engineering, Capstan Therapeutics seeks to create transformative therapeutics that can offer new solutions for patients facing these challenging conditions.

Moove

Series B in 2024
Moove is a mobility fintech company focused on providing revenue-based vehicle financing to entrepreneurs in the mobility sector across Africa. By utilizing embedded alternative credit-scoring technology within ride-hailing, logistics, and delivery platforms, Moove aims to democratize vehicle ownership and improve access to financial services for those previously excluded. The company's innovative approach leverages proprietary performance and revenue analytics to assess and underwrite loans, enabling mobility entrepreneurs to secure the financing needed to grow their businesses. Through this model, Moove addresses the financial barriers faced by individuals in the mobility industry, promoting economic empowerment and expanding opportunities for entrepreneurship.

Truist Insurance Holdings

Private Equity Round in 2024
Truist Insurance Holdings is a subsidiary of Truist Financial Corporation and the sixth-largest insurance brokerage.

Manipal Hospitals

Secondary Market in 2024
Manipal Hospitals, part of the Manipal Education and Medical Group, is a significant player in India's healthcare sector, particularly in South India. Established over five decades ago, it has grown to become the country's third-largest healthcare group, operating a network of 15 hospitals and three primary clinics. The organization offers comprehensive healthcare services that encompass both curative and preventive care, addressing a wide range of medical issues from minor ailments to complex conditions. Catering to both Indian and international patients, Manipal Hospitals focuses on delivering quality and affordable healthcare, contributing to the well-being of diverse communities.

Ciitizen

Seed Round in 2023
Ciitizen’s mission is to provide Earth’s 7.3 billion citizens with control of their complete health information and give them the choice of sharing it with whomever they want. Period. With this new ownership, patients can share their health history with caregivers, share for second opinions, and with companies/researchers who may hold the answer to their treatment. All patients have a right to all of their health information, yet existing portals pull only minimal clinical information from a fraction of health care institutions. Current “interoperability” initiatives leave the patient out of the picture and often rely on armies of manual labor to extract key health insights from unstructured textual data—an expensive model which doesn’t scale. In the near future, citizens will walk into a clinical facility and, with a simple tap of a mobile device, release their health information to themselves, where Ciitizen normalizes unstructured data from across the healthcare ecosystem into actionable visualizations for patients, their caregivers, and clinicians. Ciitizen has assembled an all-star team, led by its CEO, Anil Sethi (last company was sold to Apple) and is backed by a strong investment team led by Andreessen Horowitz, Verily, Section 32 and others.

Tabby

Series D in 2023
Tabby Inc. is a financial technology company based in the United Arab Emirates that offers payment solutions for online purchases. It operates a platform that provides customers in the UAE and Saudi Arabia with a buy now, pay later option, allowing them to make payments for their purchases either in a single deferred payment or through multiple installments. This service aims to enhance financial flexibility, enabling consumers to manage their spending more effectively while ensuring safe payment transactions. Through its innovative approach, Tabby seeks to reshape the relationship individuals have with their finances, promoting a more accessible shopping experience.

Rejuveron Life Sciences

Series B in 2023
Rejuveron Life Sciences AG, founded in 2019 and based in Zug, Switzerland, is a biotechnology platform company focused on developing and investing in therapies and technologies aimed at enhancing healthy aging and extending lifespan. The company seeks to advance innovative solutions by investing in promising ideas and talented individuals within the field of life sciences.

Getir

Series F in 2023
Getir is a mobile retailer based in Besiktas, Turkey, that specializes in the on-demand delivery of fast-moving consumer products. Founded in 2015, the company offers a wide range of items, including groceries such as milk, diapers, ice cream, and detergent. Getir operates in several cities across Turkey, including Istanbul, Izmir, Ankara, Bursa, and Kocaeli, catering to the growing demand for convenient, quick delivery services in the consumer market.

Aman Resorts

Private Equity Round in 2023
Aman Resorts is a luxury hospitality group that specializes in creating intimate and exclusive guest experiences through its small, high-end hotels and resorts. Each property is designed to harmonize with its beautiful natural surroundings, ensuring privacy and tranquility for guests. The company offers a range of services, including accommodations, dining, spa treatments, and cultural activities, all tailored to enhance the guest experience. Aman New York exemplifies this philosophy by introducing urban residences within a historically significant building, featuring unique layouts and private amenities. This urban expansion showcases Aman's commitment to providing unparalleled luxury in both remote and urban settings, maintaining its reputation for discretion and exceptional service.

Moove

Private Equity Round in 2023
Moove is a mobility fintech company focused on providing revenue-based vehicle financing to entrepreneurs in the mobility sector across Africa. By utilizing embedded alternative credit-scoring technology within ride-hailing, logistics, and delivery platforms, Moove aims to democratize vehicle ownership and improve access to financial services for those previously excluded. The company's innovative approach leverages proprietary performance and revenue analytics to assess and underwrite loans, enabling mobility entrepreneurs to secure the financing needed to grow their businesses. Through this model, Moove addresses the financial barriers faced by individuals in the mobility industry, promoting economic empowerment and expanding opportunities for entrepreneurship.

Georgiamune

Series A in 2023
Georgiamune is an immunotherapy company dedicated to advancing oncology treatments. The firm specializes in next-generation immunotherapeutic and homeostatic therapies aimed at addressing cancer and autoimmune diseases. By focusing on innovative approaches, Georgiamune seeks to enhance patient recovery from cancer, contributing to significant breakthroughs in the field of immunotherapy.

EpiBiologics

Series A in 2023
EpiBiologics focuses on developing antibody-based targeted therapies aimed at membrane and extracellular proteins that contribute to various diseases. The company utilizes its EpiTAC platform to create therapeutics that degrade these disease-driving proteins, addressing the underlying biology of disorders. By specializing in protein degradation, EpiBiologics enables researchers to manipulate cellular proteostasis, offering potential solutions for a wide range of medical conditions.

Matera

Series B in 2023
Matera, a Paris-based company incorporated in 2017, operates an online condominium management platform aimed at simplifying the lives of co-owners. The platform enables residents to effectively manage their buildings by handling administrative and accounting tasks, generating necessary documents and bills tailored to each co-owner's needs. By providing a secure online environment for these functions, Matera allows co-owners to take control of their property management without relying on traditional professional syndicates. Additionally, the platform offers legal and accounting support, further streamlining the management process for building co-owners.

GUODONG GROUP

Venture Round in 2023
GUODONG GROUP is involved in investment, building, operation, maintenance, and communication tower leasing services. They provide comprehensive information infrastructure services. They are engaged in constructing information infrastructure and offering communication services for business users.

TreasurySpring

Series B in 2023
TreasurySpring Limited is a financial technology firm established in 2016 and based in London, United Kingdom. The company operates an online platform designed to connect issuers and investors, with a focus on revolutionizing institutional short-term funding markets. TreasurySpring offers a variety of fixed-term funds, including sovereign funds that invest in government treasury bills and bonds, financial funds providing exposure to investment-grade banking institutions, and corporate funds targeting investment-grade non-financial institutions. The platform employs advanced legal, financial, and operational technologies to create new financial instruments, allowing cash-rich firms to access previously unavailable short-term investments. This innovative approach enables institutions seeking funding to reach a wider array of capital providers while enhancing security and yield.

Shein

Venture Round in 2023
Shein is an online marketplace focused on women's apparel, offering a wide range of clothing, shoes, jewelry, and accessories. Founded in 2008 and headquartered in Jiangsu, China, the company utilizes on-demand manufacturing technologies to connect suppliers with an agile supply chain, effectively reducing inventory waste. This approach allows Shein to provide affordable fast fashion products to customers in over 220 countries and regions worldwide. By emphasizing accessibility and efficiency, Shein aims to make contemporary fashion more attainable for consumers globally.

TIER Mobility

Convertible Note in 2023
TIER Mobility GmbH is a shared micro-mobility provider based in Berlin, Germany, specializing in electric vehicles for local commuting. Founded in 2018, the company offers a variety of light electric vehicles, including e-scooters, e-bikes, and e-mopeds, all accessible through a user-friendly application that allows customers to locate and book vehicles easily. TIER aims to transform urban transportation by reducing reliance on cars and promoting climate-neutral solutions that contribute to a sustainable future. Through its proprietary Energy Network, TIER is committed to fostering environmentally friendly mobility options in cities.

BrightSpeed

Private Equity Round in 2023
BrightSpeed is a broadband and telecommunications services company that serves homes and businesses. The goal of Brightspeed is to advance a society in which both individuals and organizations have access to the connectivity they require to complete important tasks. Brightspeed provides internet services without bundles, annual contracts, or data caps. The company is expanding its fiber network to improve connectivity.

Hasten

Venture Round in 2023
Hasten is a pharmaceutical manufacturing company that integrates R&D, manufacturing, and commercialization, and covers the entire industry chain. They are dedicated to creating China's innovative medical and health company, and they collaborate with key government agencies, medical and health professionals, and industry partners to provide high-quality solutions, build a health management ecosystem, and benefit more patients.

Outpace Bio

Series A in 2023
Outpace Bio is a biotechnology company that creates smart cell therapies aimed at improving efficacy and safety. It offers a platform that combines custom-designed biological functions with cellular control modalities that program the right response at the right time and place. It creates a mechanism-driven solution tailor-made to improve efficacy and safety. The company collaborates with Lyell Immunopharma to develop and commercialize a potential immune cell therapy for the treatment of cancer, auto-immune diseases, infectious diseases, degenerative diseases, regenerative medicine, metabolic disorders, and genetic disorders, enabling healthcare providers to cure a wide range of diseases as per patient's need.

EpiBiologics

Series A in 2023
EpiBiologics focuses on developing antibody-based targeted therapies aimed at membrane and extracellular proteins that contribute to various diseases. The company utilizes its EpiTAC platform to create therapeutics that degrade these disease-driving proteins, addressing the underlying biology of disorders. By specializing in protein degradation, EpiBiologics enables researchers to manipulate cellular proteostasis, offering potential solutions for a wide range of medical conditions.

Chroma Medicine

Series B in 2023
Chroma Medicine is a genomic medicine company based in Cambridge, Massachusetts, founded in 2021. The company focuses on epigenetic editing, aiming to revolutionize the treatment of genetically driven diseases. By utilizing epigenetics, which is nature's inherent mechanism for regulating genes, Chroma Medicine develops programmable epigenetic editors that target specific genes and control chromatin conformation. This innovative approach combines a DNA binding domain with epigenetic effector domains, providing medical practitioners with a new class of therapeutics that offers enhanced control over gene expression.

TIER Mobility

Venture Round in 2023
TIER Mobility GmbH is a shared micro-mobility provider based in Berlin, Germany, specializing in electric vehicles for local commuting. Founded in 2018, the company offers a variety of light electric vehicles, including e-scooters, e-bikes, and e-mopeds, all accessible through a user-friendly application that allows customers to locate and book vehicles easily. TIER aims to transform urban transportation by reducing reliance on cars and promoting climate-neutral solutions that contribute to a sustainable future. Through its proprietary Energy Network, TIER is committed to fostering environmentally friendly mobility options in cities.

Truist Insurance Holdings

Secondary Market in 2023
Truist Insurance Holdings is a subsidiary of Truist Financial Corporation and the sixth-largest insurance brokerage.

Precision Neuroscience

Series B in 2023
Precision Neuroscience is a company focused on developing advanced brain-computer interface technology aimed at offering innovative treatments for the approximately one billion individuals worldwide affected by neurological disorders. Founded in 2021 and based in New York, the company's technology is characterized by its minimally invasive design, safety for removal, and capacity for processing substantial data. This platform enables medical professionals to establish a direct connection between the human brain and artificial intelligence, potentially transforming the landscape of neurological care.

Paradigm

Series A in 2023
Paradigm is rebuilding the clinical research ecosystem by developing a platform that allows all patients equitable access to trials while improving trial efficiency and lowering barriers to participation for healthcare providers. It is an innovative company that is dedicated to transforming the clinical research ecosystem. Their mission is to create a more accessible and equitable healthcare system by developing a platform that enables patients from diverse backgrounds to participate in clinical trials. Clinical trials are essential for testing and developing new drugs, therapies, and medical devices, but historically, they have been plagued by inefficiencies, barriers to access, and inequities in patient representation. Paradigm aims to solve these challenges by creating a platform that uses technology and data-driven insights to streamline the clinical trial process, making it more efficient, cost-effective, and inclusive. The Paradigm platform is designed to facilitate seamless communication and collaboration among all stakeholders involved in clinical research, including patients, healthcare providers, pharmaceutical companies, and regulatory agencies. By leveraging technology such as AI, machine learning, and predictive analytics, Paradigm can identify and match eligible patients to clinical trials, streamline the recruitment and enrollment process, and provide real-time data insights to all stakeholders. Overall, Paradigm's innovative approach to clinical research has the potential to revolutionize the healthcare industry by improving patient outcomes, reducing healthcare costs, and accelerating the development of new treatments and therapies.

Tabby

Series C in 2023
Tabby Inc. is a financial technology company based in the United Arab Emirates that offers payment solutions for online purchases. It operates a platform that provides customers in the UAE and Saudi Arabia with a buy now, pay later option, allowing them to make payments for their purchases either in a single deferred payment or through multiple installments. This service aims to enhance financial flexibility, enabling consumers to manage their spending more effectively while ensuring safe payment transactions. Through its innovative approach, Tabby seeks to reshape the relationship individuals have with their finances, promoting a more accessible shopping experience.

Resilience

Private Equity Round in 2023
Resilience is a technology-driven biomanufacturing company focused on enhancing access to complex medicines, including biologics, vaccines, nucleic acids, and cell and gene therapies. The firm aims to transform the production of medicine by providing a comprehensive range of customized manufacturing capabilities that cater to the diverse needs of biopharmaceuticals throughout all stages of drug development, from pre-clinical to commercial supply. Resilience is committed to creating a sustainable network of advanced manufacturing solutions that ensure rapid, safe, and scalable production of treatments, thereby enabling partners to concentrate on breakthrough discoveries that improve patient outcomes. The company's innovative approach also strengthens biopharmaceutical supply chains, preparing them for future challenges.

Upstream Health

Series B in 2023
Upstream Health, founded in 2018 and based in North Lincolnshire, United Kingdom, specializes in developing innovative technologies and service approaches for health and social care teams. The company leverages artificial intelligence alongside a mobile and analytics platform to promote a preventive care model. By focusing on an "upstream" strategy, Upstream Health aims to enhance citizen outcomes and improve patient care through its electronic medical record innovation technology. The team comprises experienced technologists and health service innovators dedicated to addressing the evolving needs of the health and social care systems.

ACTIVE Al Maryah

Venture Round in 2023
ACTIVE Al Maryah is a sports and recreation company that specializes in the construction and management of both indoor and outdoor sports facilities. The company operates a multi-sport venue designed to promote an active lifestyle, offering well-maintained courts for various sports including football, padel, and tennis. With a focus on exceptional service, ACTIVE Al Maryah provides a welcoming environment for individuals and families, encouraging community engagement and healthy living throughout the year.

ACX

Convertible Note in 2022
ACX Group a leading environmental markets exchange, caters to corporates, financial traders, carbon project developers and other industry stakeholders. ACX leverages its proprietary technology to facilitate and scale growth of the environmental product markets to align with global ambitions of achieving Net Zero. ACX Group, including the regulated ACX Exchange (operated by ACX Ltd and ACX Clearing Corporation Ltd) and the Singapore based AirCarbon Pte. Ltd., provides corporates, financial entities, carbon project developers and other market participants, with an efficient and transparent means of trading environmental instruments. Through leveraging distributed ledger technology, ACX provides a seamless and user-friendly platform, with the lowest transaction fees in the market, to facilitate growth of environmental instrument markets and contribute to the necessary transition to a net zero global economy.

Vevo Therapeutics

Seed Round in 2022
Vevo Therapeutics, a biotechnology startup, searches for better treatments for more patients using their Mosaic in vivo drug discovery platform and next-generation AI algorithms.

UpStream Care

Series B in 2022
UpStream Care is a primary care services and technology company providing physicians with support and systems. It allows physicians to focus on what they and their patients value the most. Their intelligent technology platform, which integrates with all physician EMRs and provides an elegant workflow for all care coordination activities, augments this in-person clinical support.

ACX

Private Equity Round in 2022
ACX Group a leading environmental markets exchange, caters to corporates, financial traders, carbon project developers and other industry stakeholders. ACX leverages its proprietary technology to facilitate and scale growth of the environmental product markets to align with global ambitions of achieving Net Zero. ACX Group, including the regulated ACX Exchange (operated by ACX Ltd and ACX Clearing Corporation Ltd) and the Singapore based AirCarbon Pte. Ltd., provides corporates, financial entities, carbon project developers and other market participants, with an efficient and transparent means of trading environmental instruments. Through leveraging distributed ledger technology, ACX provides a seamless and user-friendly platform, with the lowest transaction fees in the market, to facilitate growth of environmental instrument markets and contribute to the necessary transition to a net zero global economy.

Ramp Network

Series B in 2022
Ramp Network is a fintech startup founded in 2017 and based in Warsaw, Poland. The company specializes in creating payment infrastructure that connects cryptocurrency with traditional financial systems. Its mission is to establish a seamless and accessible bridge between the open blockchain financial ecosystem and established banking systems, eliminating the need for intermediaries. Ramp Network's platform integration serves a diverse range of clients, including enterprises, gaming companies, non-fungible token marketplaces, decentralized finance businesses, and digital wallets. By facilitating fiat-crypto transactions, Ramp enables these clients to offer their users an efficient way to engage with digital assets within their products.

Juvena Therapeutics

Series A in 2022
Juvena Therapeutics, Inc. is a biopharmaceutical company based in San Mateo, California, founded in 2017. The company specializes in developing protein-based therapeutics aimed at promoting tissue rejuvenation and addressing age-related diseases in the elderly. Its innovative platform focuses on discovering novel therapeutics that restore cellular functions, targeting conditions such as sarcopenia, wound healing, and neural regeneration. By decoding secreted proteins, Juvena Therapeutics aims to provide solutions for chronic and rare diseases, enhancing the quality of life for aging populations.
Recursion Pharmaceuticals is a clinical-stage biotechnology company based in Salt Lake City, Utah, focused on transforming drug discovery through the integration of technology, particularly artificial intelligence, automation, and bioinformatics. Founded in 2013, the company utilizes a sophisticated drug discovery platform that includes various software solutions and robotic automation to enhance chemical compound selection, streamline experimental workflows, and evaluate drug efficacy. Key components of this platform involve tools for designing chemical compounds, planning complex experiments, and analyzing data to understand drug interactions and biological responses. By creating one of the largest proprietary biological and chemical datasets, Recursion aims to uncover new biological insights and expedite the development of innovative treatments, ultimately improving patient outcomes.

GlobalConnect

Secondary Market in 2022
GlobalConnect is a prominent provider of fiber network, data center, and managed hosting services in Northern Europe, particularly Denmark and Germany. Founded in 1998 by Niels Zibrandtsen, the company operates an extensive optical fiber network spanning 12,500 kilometers and offers approximately 13,000 square meters of data center space. GlobalConnect delivers a range of services, including bandwidth connectivity, colocation, cloud infrastructure, and managed hosting, catering to both enterprises and consumers. With a workforce of over 200 employees, the company aims to enhance connectivity and support businesses in achieving efficient networking solutions.

Neumora Therapeutics

Series B in 2022
Neumora Therapeutics is a clinical-stage biotechnology company focused on developing precision medicines for brain diseases by combining data science with neuroscience. Founded to address the global brain disease crisis, Neumora takes an innovative approach to treatment development. The company has established a robust therapeutic pipeline that includes seven clinical and preclinical neuroscience programs targeting novel mechanisms of action for various underserved neuropsychiatric and neurodegenerative disorders. Neumora plans to advance its pipeline further by initiating multiple clinical trials across its programs in the upcoming 12 to 18 months.

CERC Central de Recebíveis

Venture Round in 2022
CERC Central de Recebíveis S.A. is a financial technology company based in São Paulo, Brazil, that specializes in enhancing the use of receivables in credit operations. Founded in 2015, CERC has developed an intelligent platform designed to provide security and efficiency for lenders utilizing receivables as collateral. The company aims to transform the credit market by facilitating accelerated and sustainable credit growth for businesses of various sizes. By focusing on improving the infrastructure surrounding credit transactions, CERC seeks to increase the overall reliability of receivable-based lending.

Alloy Therapeutics

Series D in 2022
Alloy Therapeutics is a biotechnology company founded in 2017 and headquartered in Waltham, Massachusetts. The firm specializes in democratizing access to drug discovery through its innovative platforms and services. Its flagship offering, Alloy-Gx, is a suite of immunocompetent transgenic mice designed for optimal in vivo human antibody discovery. This royalty-free platform allows researchers broad and non-exclusive access to essential drug discovery tools, streamlining the process of antibody project development. By providing these resources, Alloy Therapeutics aims to facilitate advancements in antibody research and ultimately enhance the drug discovery landscape.

Pretzel Therapeutics

Series A in 2022
Pretzel was founded by some of the world’s foremost academics in mitochondrial biology, and we benefit from the leadership of accomplished experts in drug discovery, drug development, and company formation. Our name is inspired by the focal point of our science, the mitochondrion, whose highly folded inner membrane is one of many fascinating features that make it unlike any other organelle in the body.

TruKKer

Series C in 2022
TruKKer is a technology-enabled truck aggregator founded in 2016 and based in Abu Dhabi, UAE. The company operates a logistics and fleet management platform that simplifies road freight and logistics operations by connecting shippers with available trucks in real-time. This integration of supply and demand enhances asset utilization, reduces transportation costs, and provides reliable cross-border services. TruKKer's cloud-based freight solutions offer comprehensive coverage and a full-service portfolio for shippers, carriers, and businesses, leveraging real-time data analytics to ensure transparency and efficiency. The company’s rapid growth has opened up opportunities for data monetization and consolidated procurement, further solidifying its position in the logistics market.

Spotnana

Series B in 2022
Spotnana is a travel platform that aims to modernize the infrastructure of the travel industry, enhancing the experience for both corporations and consumers. Its innovative Travel-as-a-Service platform simplifies and reduces costs associated with travel, while also modernizing the way travel suppliers manage and sell their inventory. By doing so, Spotnana enables companies to offer superior global travel experiences to their customers, fostering transparency and trust in the travel process. The platform is designed to connect people and make travel more accessible and efficient for everyone.

Auron Therapeutics

Series A in 2022
Auron Therapeutics is to develop therapies to cure cancer by radically changing the paradigm of cancer therapeutics from cell killing, to transformation of malignant cells into normal cells. This transformation, called differentiation therapy, reactivates endogenous cellular programs to elicit tumor cell maturation and the transition from cancer to normal tissue. Its unique platforms allow for integration of large-omic datasets and miniaturized high throughput flow cytometry to rapidly identify and validate multiple targets and drugs in primary human patient samples.

Flip

Series B in 2022
Flip is a social shopping app that merges social media and e-commerce, allowing customers to engage with beauty products through video reviews. The platform enables users to discover products via short, user-generated videos, creating a dynamic shopping experience. Customers can receive clothing tailored to their preferences and share their try-on photos within the Flip community, seeking feedback from friends to enhance their decision-making process. By facilitating instant access to a community of shoppers and creators, Flip provides brands with tools to launch social commerce initiatives and connect with potential buyers. The platform emphasizes peer validation, enabling shoppers to make informed purchases with a seamless one-click checkout option.

Xilis

Series A in 2022
Xilis, Inc. is a biotechnology company based in Chapel Hill, North Carolina, founded in 2019. It specializes in developing advanced organoid technologies aimed at guiding precision therapy for cancer patients and enhancing drug discovery processes. The company's flagship platform, XilisµO, facilitates rapid diagnostics and personalized drug screening while providing scalable, patient-derived models for high-throughput drug discovery. This technology supports physicians and pharmaceutical companies in creating tailored treatments by enabling effective drug screening, ultimately contributing to more precise and cost-efficient cancer therapies.

Klarna

Venture Round in 2022
Klarna Inc. is an e-commerce payment solutions platform that facilitates cashless transactions for both merchants and shoppers. Founded in 2005 and headquartered in Columbus, Ohio, with additional offices in New York City, Klarna operates as a subsidiary of Klarna Bank AB. The company provides a range of payment options, including direct payments, pay-after-delivery choices, and installment plans, enabling customers to select their preferred payment method. Known for its "buy now, pay later" model, Klarna offers interest-free financing for retail purchases, enhancing the shopping experience. Additionally, the Klarna app provides users with flexible payment options and cashback rewards, while the platform supports in-store, mobile, and online payments, along with services for deliveries and returns.

Proximie

Series C in 2022
Proximie Inc. is a health technology company based in Bedford, Massachusetts, that specializes in a telehealth platform designed for virtual surgical assistance. Founded in 2016 by Nadine Hachach-Haram, Proximie's platform enables surgeons to remotely observe and guide complex surgical procedures using augmented reality, artificial intelligence, and machine learning. This technology allows expert surgeons to connect with their peers globally, sharing knowledge and skills in real-time, regardless of their physical location. The platform is adaptable, compatible with various devices and software used in operating rooms, and can function effectively even in low bandwidth environments. Proximie aims to enhance surgical practices by democratizing access to expert guidance and fostering collaboration among medical professionals.

Juni

Series B in 2022
Juni is a fintech company that offers a banking app and platform tailored for e-commerce and online marketing entrepreneurs. The platform provides an integrated payment solution that allows users to track all their financial activities from a centralized dashboard, giving them a comprehensive overview of their bank accounts, networks, and payment services. By delivering detailed customizable financial reports, Juni empowers digital entrepreneurs to make informed decisions and effectively scale their operations, maximizing the potential of their digital commerce ventures.

Medicina UniFTC

Acquisition in 2022
UniFTC Medicine is designed to train complete doctors and doctors, who will act in an efficient and humanized way, having technologies as an ally. It is Medicine transforming your future for you to transform the future of the world.

Unesulbahia

Acquisition in 2022
Unesulbahia is located in Eunápolis and currently offers nine undergraduate courses: Medicine, Biomedicine, Nursing, Pharmacy, Physiotherapy, Dietetics and Law. Unesulbahia are permanently enhanced through the Structuring Teaching Center, a group made up of 16 medical professors with renowned academic background and extensive professional experience.

SpotOn

Series F in 2022
SpotOn is a company dedicated to empowering small and midsize businesses by providing innovative software and payment solutions, complemented by personalized local service. Founded in 2017 and headquartered in San Francisco, SpotOn is recognized for its comprehensive integrated systems designed for the restaurant and retail sectors. Its offerings include point-of-sale solutions, marketing tools, website development, online ordering, appointment scheduling, eCommerce, digital loyalty programs, and review management. The platform is cloud-based, allowing businesses to enhance their operational efficiency and customer engagement through analytics and consistent communication strategies. SpotOn aims to deliver these services at a fair price, positioning itself as a valuable partner for business growth and development.

Storyblok

Series B in 2022
Storyblok GmbH operates a cloud-based content management platform that enables users to upload, manage, and publish content through its APIs. Founded in 2015 and headquartered in Linz, Austria, Storyblok distinguishes itself with customizable content blocks and visual editing tools, catering to both developers and content editors. Unlike traditional headless content management systems, which may prioritize flexibility for developers, Storyblok emphasizes usability for editors, allowing them to create and manage content without requiring coding skills. The platform includes features such as a visual composer, various content types, and extensive API endpoints for e-commerce, facilitating a seamless user experience while handling complex tasks like order management and multilingual product catalogs.

HiveMQ

Series A in 2022
HiveMQ specializes in providing a robust MQTT (Message Queuing Telemetry Transport) platform that facilitates the connection, communication, and management of IoT data in demanding real-world environments. The platform serves various industries, including automotive, energy, logistics, smart manufacturing, and transportation, offering flexibility, security, and scalability for mission-critical applications. Prominent companies such as Audi, BMW, Honeywell, Mercedes-Benz, and Siemens utilize HiveMQ to enhance their IoT projects, modernize manufacturing processes, and improve customer experiences. By enabling architects and developers to effectively implement IoT solutions, HiveMQ positions itself as a trusted standard in the enterprise sector.

Unlearn.AI

Series B in 2022
Unlearn.AI, Inc. is a biotechnology company that specializes in developing software tools for clinical research, focusing on improving diagnosis and treatment processes. Based in San Francisco, the company offers solutions such as Clinical Trial Design, which helps define inclusion criteria, endpoints, and study sizes; Synthetic Control Arms, which reduce or eliminate the necessity for concurrent control groups; and Subgroup Analysis, which identifies specific patient subgroups within trial results. Unlearn.AI has pioneered the TwinRCT solution, a digital twin service that leverages machine learning to enhance the efficiency and success rates of clinical trials. This innovative approach creates a prognostic digital twin for each patient, allowing for more precise estimations of treatment effects based on historical data. By integrating machine learning and biostatistics, Unlearn.AI aims to accelerate the clinical trial process, benefiting both patients and pharmaceutical sponsors.

Welcome Tech

Venture Round in 2022
Welcome Tech is a platform focused on supporting the 250 million global immigrant communities by connecting them with essential information, products, and services. The company serves over 9 million immigrants annually and has nearly 2 million active users. By utilizing a data-driven approach, Welcome Tech offers tailored solutions across various sectors, including finance, education, healthcare, telecommunications, and government services. Founded by experts in immigration and technology, the platform employs proprietary data and recommendation algorithms to deliver relevant services that empower immigrant families. Headquartered in Los Angeles, California, Welcome Tech aims to help immigrants become informed, confident, and active participants in their new communities.

Ansa Biotechnologies

Series A in 2022
Ansa Biotechnologies is manufactured via a chemical method that has remained essentially unchanged for 35 years and has approached a plateau. Ansa Biotechnologies is developing a novel DNA synthesis technology based on enzymes that will be more fast, accurate, and clean than existing methods. The technique promises to dramatically accelerate innovation in biological research and engineering.

re:cap

Seed Round in 2022
re:cap is a digital platform designed to streamline financing for subscription revenue companies by integrating debt funding, liquidity management, and financial operations into a single, customizable solution. This platform addresses common challenges in the subscription economy, such as equity dilution, high interest rates, and complex lending processes. By allowing companies to sell a portion of their recurring revenue for a fixed period, re:cap enables businesses to access on-demand, non-dilutive capital. The platform seeks to eliminate manual workflows and scattered insights, providing a cohesive approach to financial products and operations, ultimately helping businesses close funding gaps efficiently.

Coin Metrics

Series C in 2022
Coin Metrics Inc. is a provider of blockchain and cryptocurrency data, offering comprehensive market and network analytics to various industries. The company delivers a range of services, including the CM Network Data Pro, which provides historical crypto network data aggregated daily for prominent assets, and the CM Market Data Feed, which standardizes trade, candle, and order book data across multiple exchanges. Additionally, Coin Metrics offers CM Reference Rates, which provide fixed pricing for various assets quoted in U.S. dollars. Founded in 2017 and based in Cambridge, Massachusetts, Coin Metrics aims to empower institutions and individuals to make informed decisions regarding crypto assets by providing transparent and actionable data analytics.

CityFibre

Private Equity Round in 2022
CityFibre is an independent provider of fiber infrastructure primarily focused on secondary cities. The company develops and manages digital infrastructure that enables wholesale customers, including service integrators and mobile operators, to deliver broadband, Ethernet, and 5G services. By specializing in full fiber solutions, CityFibre supports a range of clients, from consumer service providers to enterprises, ensuring they can offer ultra-fast and reliable connectivity to various locations, such as homes, schools, and hospitals.

Getir

Series E in 2022
Getir is a company that specializes in urban logistics and mobile technology, offering instant delivery of groceries and other goods through its user-friendly application. Launched in 2015 and based in Istanbul, the platform allows customers to order a wide range of products and pay securely via credit card. The app also features live tracking, enabling users to monitor the location of their orders in real-time. By facilitating quick and convenient access to essential items, Getir aims to enhance the shopping experience for urban consumers.

Tabby

Series B in 2022
Tabby Inc. is a financial technology company based in the United Arab Emirates that offers payment solutions for online purchases. It operates a platform that provides customers in the UAE and Saudi Arabia with a buy now, pay later option, allowing them to make payments for their purchases either in a single deferred payment or through multiple installments. This service aims to enhance financial flexibility, enabling consumers to manage their spending more effectively while ensuring safe payment transactions. Through its innovative approach, Tabby seeks to reshape the relationship individuals have with their finances, promoting a more accessible shopping experience.

Balbix

Series C in 2022
Balbix, Inc. is a cybersecurity company that provides a predictive breach risk and resilience platform aimed at enhancing the security posture of organizations. Founded in 2015 and based in San Jose, California, Balbix uses artificial intelligence and predictive analytics to assess and visualize an enterprise's cyber-breach risk across all devices, users, and applications. The platform enables security teams to conduct risk-based vulnerability management, accurately inventory assets, and quantify cyber risks in monetary terms. By predicting critical breach scenarios, Balbix helps organizations prioritize their security operations and projects, ultimately improving their overall cyber resilience. The company has gained recognition as a leader in cybersecurity posture automation and has been acknowledged as a noteworthy player in the industry.

Weavr

Series A in 2022
Weavr operates a cloud-based platform that connects payment networks and financial providers, enabling companies to easily integrate banking and financial services into their offerings through APIs. The platform provides a range of financial solutions for both consumers and businesses, including options for accounts with or without IBANs, virtual and physical cards, and wearables. By offering comprehensive tools for creating, deploying, and managing digital payment flows, Weavr allows digital businesses to embed financial services within their applications while alleviating the burdens of data security and regulatory compliance.

Princeton Digital Group

Private Equity Round in 2022
Princeton Digital Group is an internet infrastructure company that collaborates with hyperscalers and enterprises to meet their infrastructure requirements across Asia, including China, Singapore, India, and Indonesia. The company offers a comprehensive range of services, including construction, data wholesale, and operation and maintenance management. By optimizing industrial structures and enhancing the industrial ecosystem, Princeton Digital Group supports the growth of local hyperscalers and enterprises. Their services enable center operators, cloud service providers, financial institutions, and other enterprises to identify under-invested assets, monetize content on the internet and mobile platforms, and ultimately maximize returns and value creation. Backed by Warburg Pincus, the firm is well-positioned to address the evolving demands of the digital landscape.

Kallyope

Series D in 2022
Kallyope Inc. is a biotechnology company based in New York City that focuses on the gut-brain axis to develop innovative therapeutics and consumer products aimed at enhancing human health. Founded in 2014, Kallyope employs a multidisciplinary approach, integrating technologies such as sequencing, computational biology, neural imaging, and human genetics to deepen the understanding of gut-brain biology. This comprehensive understanding enables the company to create effective and well-tolerated oral medications targeting various health issues, including diabetes, obesity, gut disorders, inflammatory diseases, migraines, and allergies. With a team of experienced scientists and a strong foundation in drug discovery, Kallyope aims to address significant unmet medical needs through its research and development efforts.

TruKKer

Series B in 2022
TruKKer is a technology-enabled truck aggregator founded in 2016 and based in Abu Dhabi, UAE. The company operates a logistics and fleet management platform that simplifies road freight and logistics operations by connecting shippers with available trucks in real-time. This integration of supply and demand enhances asset utilization, reduces transportation costs, and provides reliable cross-border services. TruKKer's cloud-based freight solutions offer comprehensive coverage and a full-service portfolio for shippers, carriers, and businesses, leveraging real-time data analytics to ensure transparency and efficiency. The company’s rapid growth has opened up opportunities for data monetization and consolidated procurement, further solidifying its position in the logistics market.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.